Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 431

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 431
---
);                                                                                |

<div align='center'>F-102

NORTHVIEW ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div>

Note 6 — Commitments and Contingencies
(cont.)

| (b) | Provided a registration statement is effective for the shares                                                                             
 underlying the Initial Note, New Profusa Common Stock has traded a volume of at least $35,000,000 in the aggregate after the $2,000,000   
 Second Purchase has closed, no default or event of default has occurred and the stock has traded at a trading price of no less than $4.00 
 for a period of five trading days preceding such purchase, the Company may call and thereby require the Investor to purchase Convertible  
 Notes in the aggregate principal amount of $5,555,555 for a purchase price of $5,000,000 (reflecting a 10% OID); and                      |

| (c) | The Investor at its sole discretion may call from the Company                                                                           
 and thereby require the Company to sell an additional Convertible Note having an aggregate principal amount of $4,444,444 at a purchase 
 price of $4,000,000 (reflecting a 10% OID) to be purchased at any time within 12 months of the Initial Closing.                         |

As a result of the Business
Combination, the Company paid $90,000 at the Closing to an advisor for legal services in connection with the issuance of the Convertible
Note.

Note 7 — Stockholders’ Deficit

Preferred stock — The
Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and with such designations,
rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2025
and December 31, 2024, there was no preferred stock issued or outstanding.

Common Stock— The
Company is authorized to issue a total of 100,000,000 shares of common stock at par value of $0.0001 each. In April 2021,
the Company issued 5,175,000 shares of common stock to its Sponsor for $25,000, or approximately $0.005 per share. In October 2021,
the Sponsor irrevocably surrendered to the Company for cancellation and for no consideration 862,500 shares of common stock. On